Rb1蛋白质水平预测某些乳腺癌对有针对性的治疗的反应,推动个性化治疗。 Rb1 protein levels predict response to targeted therapy in some breast cancers, advancing personalized treatment.

研究人员已确定Rb1蛋白质是某些乳腺癌新治疗战略的预测生物标志,有可能指导有特定肿瘤特征的病人的治疗决定。 Researchers have identified the Rb1 protein as a predictive biomarker for a new therapeutic strategy in certain breast cancers, potentially guiding treatment decisions for patients with specific tumor profiles. 发现后可以采取更个性化的方法,特别是针对Rb1功能正常的肿瘤,表明对有针对性的疗法的反应。 The discovery could enable more personalized approaches, particularly for tumors where Rb1 is functional, suggesting responsiveness to targeted therapies. 调查结果表明,在乳腺癌护理方面,向精密医学迈出了重要一步。 The findings represent a significant step toward precision medicine in breast cancer care.